The recent advances in the field of molecular diagnostic techniques have led to the identification of targetable alterations prompting a paradigm shift in the management of non-small cell lung cancer (NSCLC) and an era of precision oncology. This Element highlights the most clinically relevant oncogenic drivers other than EGFR, their management and current advancements in treatment. It also examines the different challenges in resistance to targeted therapies and diagnostic dilemmas for each oncogenic driver and the future direction of NSCLC management.
Bu e-kitabı satın alın ve 1 tane daha ÜCRETSİZ kazanın!
Dil İngilizce ● Biçim EPUB ● ISBN 9781009336093 ● Yayımcı Cambridge University Press ● Yayınlanan 2023 ● İndirilebilir 3 kez ● Döviz EUR ● Kimlik 8807931 ● Kopya koruma Adobe DRM
DRM özellikli bir e-kitap okuyucu gerektirir